Author: Jim Sagar

CIMS Global CEO Dr. Tai Xie presented the concept of DDM – Dynamic Data Monitoring – at the JSM conference in Denver, Colorado on July 27, 2019. DDM is an innovative design that combines Dynamic Adaptive Design (DAD) with a data-guided analysis for timing the SSR. The DDM process covers: Continuously monitoring on-going data Data-guided…

Recently, CIMS Global founder Dr. Tai Xie presented at the Innovative Trial Design Symposium in Beijing. His talk, titled Dynamic Adaptive Design and Dynamic Data Monitoring, focused on how machine learning and artificial intelligence can reshape the future of clinical trials. By using a new approach called Dynamic Adaptive Design, (DAD), supported by real-time patient…

About the Innovative Trial Design Group (ITDG) CIMS, the pioneer of dynamic trial design (DTD) and dynamic data monitoring (DDM), announced new services offered to the pharmaceutical and biotech industry. The new services include, but are not limited to, the following: Innovative Trial Design Group Sequential Design Adaptive Sequential Design Dynamic Adaptive Design Phase II/III…

CIMS Global founder Dr. Tai Xie, an industry pioneer focused on reshaping the future of clinical trials through the convergence of EDC and IWRS, statistical modeling and machine learning, will be speaking at DIA China on May 22, 2019. Dr. Xie’s talk, titled Use of EHR Data in Clinical Trials (Understanding FDA’s Recent Guidance), will…

CIMS Global, the pioneer of dynamic trial design (DTD) and dynamic data monitoring (DDM), has added another clinical trial expert to its advisory board. Kuang-Kuo Gordon Lan will serve as a Sr. Advisor and received his PhD in Mathematical Statistics (1974) from Columbia University and is serving as CIMS Senior Statistical Advisor. Dr. Lan has published…